Celldex Therapeutics, Inc. (CLDX) Earnings
|
Expand Research on CLDX
| Next EPS Date | 8/6/26 | EPS Growth Rate | -23.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.5% | Revenue Growth Rate | +10.0% |
| Average % Move 1-Wk after EPS | +7.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$1.05 | N/A | N/A | $802.64K | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$1.18 | -$1.19 | +$0.01 | $15K | $874.9K | N/A |  | | Details | |
| 5/4/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$1.19 | N/A | N/A | $874.9K | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$1.01 | N/A | N/A | $1.39M | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | -$1.01 | -$0.90 | -$0.11 | N/A | $1.08M | N/A | | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.90 | N/A | N/A | $1.08M | N/A | N/A | N/A |
